Cohort Study on the Treatment of Severe Pneumonia with Traditional Chinese Medicine
Ориентир для пациента и семьи
Простыми словами
Автоматическая сводка по структурированным данным реестра. Она помогает сориентироваться, но не заменяет официальный протокол или оценку врача.
- Что изучают
- В протоколе указаны: traditional Chinese medicine (TCM), non traditional Chinese medicine (non-TCM).
- Кому может быть актуально
- Состояния в реестре: Community-Acquired Infections. Базовые параметры: от 18 лет · Все.
- Что важно проверить
- Возраст, диагноз и пол — только базовые ориентиры. Предыдущее лечение, анализы и другие обязательные условия указаны ниже в критериях участия.
- Где проводится
- Китай
- Следующий шаг
- Сохраните исследование, покажите его лечащему врачу и уточните актуальный статус у исследовательского центра. Расходы, документы и поездка →
Не всё понятно в терминах? Прочитайте наш гид для пациентов →
Официальное название
Cohort Study on the Efficacy of Traditional Chinese Medicine Syndrome Differentiation Scheme in Adjuvant Treatment of Severe Pneumonia Based on the Real World
Обзор
This is a multicenter, prospective cohort study, with syndrome differentiation and treatment of traditional Chinese medicine as the exposure factor. Patients using syndrome differentiation of traditional Chinese medicine combined with conventional treatment of Western medicine are classified as the treatment cohort of Integrated Chinese and Western medicine, and patients using conventional treatment of Western medicine only are classified as the treatment cohort of Western medicine
Подробное описание
Severe pneumonia is a severe respiratory disease with high mortality, many complications and poor prognosis. Traditional Chinese medicine has certain curative effect in the adjuvant treatment of severe pneumonia, but there is a lack of systematic TCM syndrome differentiation scheme and its curative effect evaluation in the real medical environment. The cohort study on the efficacy of TCM syndrome differentiation scheme in the adjuvant treatment of severe pneumonia is conducive to providing new evidence for the optimization and evidence-based evaluation of TCM treatment scheme for severe pneumonia. Therefore, this study took severe pneumonia as the research object, standardized use of traditional Chinese medicine diagnosis and treatment scheme as the exposure factor, carried out a multi center prospective cohort study, used the 90 day mortality, 28 day mortality, treatment failure rate, etc., to evaluate the clinical efficacy and safety of integrated traditional Chinese and Western medicine in the treatment of severe pneumonia, and provided evidence for the application and promotion of traditional Chinese medicine in severe pneumonia.
Вмешательства
- Препарат traditional Chinese medicine (TCM)
Taking the use of traditional Chinese medicine syndrome differentiation treatment as the exposure factor, the continuous use of traditional Chinese medicine for 3-5 days was defined as mild exposure, continuous use of traditional Chinese medicine for 6-10 days as moderate exposure, and continuous use of traditional Chinese medicine for more than 10 days as severe exposure. The exposed group used TCM syndrome differentiation therapy combined with conventional western medicine treatment (integrati - Препарат non traditional Chinese medicine (non-TCM)
Taking the use of traditional Chinese medicine syndrome differentiation treatment as the exposure factor, the continuous use of traditional Chinese medicine for 3-5 days was defined as mild exposure, continuous use of traditional Chinese medicine for 6-10 days as moderate exposure, and continuous use of traditional Chinese medicine for more than 10 days as severe exposure. The exposed group used TCM syndrome differentiation therapy combined with conventional western medicine treatment (integrati
Первичные конечные точки
- 90-day mortality [Срок оценки: Mortality on the 90th day of treatment]
Вторичные конечные точки (10)
- 28-day mortality [Срок оценки: Calculate the proportion of patients who died of the disease on the 28th day after discharge]
- treatment failure rate [Срок оценки: Early treatment failure was defined as clinical deterioration within 72 hours of treatment. Late treatment failure between 72 hours and to 28 days.]
- time to clinical stability [Срок оценки: every day in the treatment.]
- ICU stay time [Срок оценки: the 28 days of the treatment phase.]
- hospitalization time [Срок оценки: the 28 days of the treatment phase]
- Mechanical ventilation time [Срок оценки: the 28 days of the treatment phase]
- SOFA score [Срок оценки: The sofa scores of the first, seventh, fourteenth, twenty-first and twenty-eight days of admission and the first, second and third months after discharge were counted.]
- Quality of life [Срок оценки: The scores of the first, seventh, fourteenth, twenty-first and twenty-eight days of admission and the first, second and third months after discharge were counted]
- TCM syndrome score [Срок оценки: The TCM syndrome scores of the first, seventh, fourteenth, twenty-first and twenty-eight days and the first, second and third months after discharge were counted]
- 90 day readmission rate [Срок оценки: The proportion of rehospitalization due to exacerbation within 90 days after discharge was recorded]
Критерии участия
Критерии включения
- It met the diagnostic criteria of severe pneumonia;
- Age ≥ 18 years old, regardless of gender.
- Voluntary treatment.
- Sign the informed consent form.
Критерии исключения
- Pregnant or lactating women;
- Patients with mental illness who are unable to cooperate or unwilling to cooperate with follow-up;
- Those who are participating in clinical trials of other drugs;
- Known allergic to therapeutic drugs.
Критерии приведены из реестра в оригинале (на английском). Окончательную оценку соответствия проводит исследовательский центр.
Здоровые добровольцы: Нет
Дизайн исследования
- Модель наблюдения
- Когортное
Центры проведения
Китай · 1 центр
- The First Affiliated Hospital of Henan University of Traditional Chinese Medicine — Чжэнчжоу
Идентификаторы
NCT: NCT06613659 · RESEARCH-SEVERE PNEUMONIA